Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Intraoperative hypotension and patient outcome: does "one size fit all?".

ABSTRACT:

SUBMITTER: Brady K

PROVIDER: S-EPMC5508107 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Intraoperative hypotension and patient outcome: does "one size fit all?".

Brady Kenneth K Hogue Charles W CW

Anesthesiology 20130901 3

PMID: 23835588

Similar Datasets

Pharmacogenomics and patient care: one size does not fit all.

Project description:The time is ripe to assess whether pharmacogenomics research--the study of the genetic basis for variation in drug response--has provided important insights into a personalized approach to prescribing and dosing medications. Here, we describe the status of the field and approaches for addressing some of the open questions in pharmacogenomics research and use of genetic testing in guiding drug therapy.

| S-EPMC3963516 | biostudies-literature

One Size Does Not Fit All.

Project description: Not available

| S-EPMC10134891 | biostudies-literature

Tissue microarrays: one size does not fit all.

Project description:BackgroundAlthough tissue microarrays (TMAs) are commonly employed in clinical and basic-science research, there are no guidelines for evaluating the appropriateness of a TMA for a given biomarker and tumor type. Furthermore, TMA performance across multiple biomarkers has not been systematically explored.MethodsA simulated TMA with between 1 and 10 cores was designed to study tumor expression of 6 biomarkers with varied expression patterns (B7-H1, B7-H3, survivin, Ki-67, CAIX, and IMP3) using 100 patients with clear cell renal cell carcinoma (RCC). We evaluated agreement between whole tissue section and TMA immunohistochemical biomarker quantification to assess how many TMA cores are necessary to adequately represent RCC whole tissue section expression. Additionally, we evaluated associations of whole tissue section and TMA expression with RCC-specific death.ResultsThe number of simulated TMA cores necessary to adequately represent whole tissue section quantification is biomarker specific. Although 2-3 cores appeared adequate for B7-H3, Ki-67, CAIX, and IMP3, even as many as 10 cores resulted in poor agreement for B7-H1 and survivin compared to RCC whole tissue sections. While whole tissue section B7-H1 was significantly associated with RCC-specific death, no significant associations were detected using as many as 10 TMA cores, suggesting that TMAs can result in false-negative findings if the TMA is not optimally designed.ConclusionsPrior to TMA analysis, the number of TMA cores necessary to accurately represent biomarker expression on whole tissue sections should be established as there is not a one-size-fits-all TMA. We illustrate the use of a simulated TMA as a cost-effective tool for this purpose.

| S-EPMC2910003 | biostudies-literature

Acetylcysteine for paracetamol: Will one size ever fit all?

Project description: Not available

| S-EPMC7082209 | biostudies-literature

Probiotics and COVID-19: one size does not fit all.

Project description: Not available

| S-EPMC7182525 | biostudies-literature

Well-being and burnout: One size does not fit all.

Project description:Well-being and burnout are concepts that have become well described throughout emergency medicine. In the past, both well-being and burnout have been defined and addressed as a singular phenomenon, similar for all physicians, regardless of career stage. However, unique stressors may exist for physicians, as a function of their work environment and stage. In this concepts article we present clinician well-being as a dynamic and continuous process, subject to unique factors along the professional lifespan. Specific individual and system-level factors are discussed, ranging from demographic variables, to evolving administrative and professional responsibilities depending on the career stage of a clinician. This detailed description of stressors spanning an emergency physician's professional career may help create more targeted physician well-being and burnout interventions.

| S-EPMC7280727 | biostudies-literature

Batch-to-Batch Variation and Patient Heterogeneity in Thymoglobulin Binding and Specificity: One Size Does Not Fit All.

Project description:Background: Thymoglobulin is used to prevent allograft rejection and is being explored at low doses as intervention immunotherapy in type 1 diabetes. Thymoglobulin consists of a diverse pool of rabbit antibodies directed against many different targets on human thymocytes that can also be expressed by other leukocytes. Since Thymoglobulin is generated by injecting rabbits with human thymocytes, this conceivably leads to differences between Thymoglobulin batches. Methods: We compared different batches for antibody composition and variation between individuals in binding to PBMC and T cell subsets, and induction of cytokines. Four different batches of Thymoglobulin were directly conjugated with Alexa-Fluor 647. Blood was collected from five healthy donors, and PBMCs were isolated and stained with Thymoglobulin followed or preceded by a panel of fluorescent antibodies to identify PBMC and T cell subsets. In addition, whole blood was incubated with unlabeled Thymoglobulin to measure cytokine induction. Results: Cluster analysis of flow cytometry data shows that Thymoglobulin bound to all PBMC subpopulations including regulatory T cells. However, Thymoglobulin binding was highly variable between donors and to a lesser extent between batches. Cytokines related to cytokine release syndrome were highly, but variably, increased by all Thymoglobulin batches, with strong differences between donors and moderate differences between batches. Discussion: The variation in Thymoglobulin binding and action between donors regarding PBMC recognition and cytokine response may underlie the different clinical responses to Thymoglobulin therapy and require personalized dose adjustment to maximize efficacy and minimize adverse side effects.

| S-EPMC11765605 | biostudies-literature

Kidney Disease Complexity Manifested: One Biomarker Size Does Not Fit All.

Project description: Not available

| S-EPMC9263414 | biostudies-literature

Does one size fit all? Developing an evaluation strategy to assess large language models for patient safety event report analysis

Project description: Not available

| S-EPMC11549957 | biostudies-literature

One size does not fit all: prediction of presence of pleural adhesions.

Project description: Not available

| S-EPMC10636472 | biostudies-literature